a-link-name=”in body link”>Last year, AstraZeneca announced a £90m state support offer from the previous government for a research and manufacturing centre in the Liverpool suburb of Speke. However, the company cancelled the project just hours after UK chancellor Rachel Reeves singled out the drugmaker as a “great companies” in her speech on UK growth. Keith Neal, emeritus professor of epidemiology of infectious diseases at the University of Nottingham, stated that this was a “potential major benefit to ensuring the vaccine supply”. Experts have questioned the way civil servants calculate value for taxpayer from big corporate investments supported by government incentives. Some have pointed to the “machinery at Whitehall”, pointing to “penny-pinching” civil servants who “don’t understand the ecosystem”
Read the full article from The Guardian here: Read More
